Table 3.

Summary performance of DCE-MRI for the diagnosis of csPCa and PCa.

	Analysis (No. of Studies)
	The diagnostic ability of DCE-MRI for csPCa in equivocal lesions (10)	The diagnostic ability of DCE-MRI for PCa in equivocal lesions (5)
Sensitivity	0.67 (95% CI, 0.56–0.76)	0.57 (0.46, 0.68)
Specificity	0.58 (95% CI, 0.46–0.68)	0.58 (0.45, 0.70)
PLR	1.6 (95% CI, 1.3–2.0)	1.4 (1.1, 1.7)
NLR	0.57 (95% CI, 0.45–0.73)	0.74 (0.59, 0.93)
DOR	3 (95% CI, 2–4)	2 (1, 3)
AUC	0.67 (95% CI, 0.63–0.71)	0.60 (0.55–0.64)

PCa, prostate cancer; csPCa, clinically significant prostate cancer; PLR, positive likelihood ratio; NLR, negative likelihood ratio; DOR, diagnostic odds ratios; AUC, the area under the summary receiver operating characteristic curves; CI, confidence intervals.